Ventricular tachycardia ablation in patients with structural heart disease: single centre experience
| Autor: | Taylan Akgun, Abdulkadir Uslu, Alper Kepez, Serdar Demir, Kamil Gulsen, Ayhan Kup, Fethullah Kayan |
|---|---|
| Přispěvatelé: | Uslu, Abdulkadir, Kup, Ayhan, Demir, Serdar, Gulsen, Kamil, Kayan, Fethullah, Kepez, Alper, Akgun, Taylan |
| Rok vydání: | 2020 |
| Předmět: |
CATHETER ABLATION
medicine.medical_specialty Ischemic cardiomyopathy Heart disease business.industry medicine.medical_treatment Cardiogenic shock Radiofrequency ablation Ventricular tachycardia Ventricular tachycardia Radiofrequency ablation Cardiomyopathies Ablation medicine.disease Tıp Single centre Ventricular tachycardia ablation Internal medicine medicine Cardiology Medicine In patient Cardiomyopathies business |
| Zdroj: | Volume: 33, Issue: 1 23-26 Marmara Medical Journal |
| ISSN: | 1019-1941 1309-9469 |
| DOI: | 10.5472/marumj.681982 |
| Popis: | Objective: We intended to report our institutional experience with ventricular tachycardia (VT) ablation in patients with structural heart disease. Patients and Methods: A total of 36 consecutive patients (31 male, age: 62.8 ± 13.2 years) who had undergone VT ablation in our institution between 01.01.2017 and 01.05.2019 were included in the analysis. Results: A total of 27 patients with the diagnosis of ischemic cardiomyopathy and 9 patients with the diagnosis of nonischemic cardiomyopathy had undergone VT ablation. VT ablation was successful in 32 (88.9%) patients. There were no major procedural complications; however, one patient with ischemic cardiomyopathy died 48 hours after the procedure because of post-ablation cardiogenic shock. Another patient with unsuccessful VT ablation died during hospitalization due to electrical storm. Endocardial ablation was performed in 23 (63.9%) patients and epicardial or combined endocardial and epicardial ablation was performed in 13 (36.1%) patients. Substrate ablation was the dominant strategy in 29 (80.6%) patients whereas activation mapping and isthmus ablation was performed in 7 (19.4%) patients. Conclusion: Our experience confirms the effectiveness and safety of VT ablation in patients with structural heart disease who are resistant to medical therapy and/or who receive recurrent implantable cardioverter-defibrillator shocks. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|